Cargando…
Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders with maturation and differentiation defects exhibiting morphological dysplasia in one or more hematopoietic cell lineages. They are associated with peripheral blood cytopenias and by increased risk...
Autores principales: | Symeonidis, Argiris, Chatzilygeroudi, Theodora, Chondrou, Vasiliki, Sgourou, Argyro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785516/ https://www.ncbi.nlm.nih.gov/pubmed/36555712 http://dx.doi.org/10.3390/ijms232416069 |
Ejemplares similares
-
Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients
por: Chondrou, Vasiliki, et al.
Publicado: (2017) -
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
por: Chondrou, Vasiliki, et al.
Publicado: (2018) -
The multi-faceted functioning portrait of LRF/ZBTB7A
por: Constantinou, Caterina, et al.
Publicado: (2019) -
Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis
por: Athanasopoulou, Katerina, et al.
Publicado: (2023) -
Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response
por: Siamoglou, Stavroula, et al.
Publicado: (2023)